Butrans Approval History 
- FDA approved: Yes (First approved June 30th, 2010)
- Brand name: Butrans
- Generic name: buprenorphine
- Company: Purdue Pharma L.P.
- Treatment for: Pain
Butrans (buprenorphine) is a transdermal opioid analgesic for the management of moderate to severe chronic pain in patients requiring continuous treatment for an extended period of time.
FDA Approval History for Butrans
| Date | Article |
|---|---|
| Jul 1, 2010 |  Purdue Pharma L.P. Receives FDA Approval for Butrans (buprenorphine) Transdermal System CIII |
See also...
Butrans (buprenorphine) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
